BCAX

Bicara Therapeutics Inc. $9.13 as of 2026-10-30
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.1%
Next 1 week
+0.6%
Next 1 month
+2.2%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 3
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.25%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.92 +2.2%
$24M/day volume 70% volatility -42% 1-year -70% from ATH
52-week range · 3% of the way up · -70% from the high
$8.36$30.99

Earnings Full history →

Next report 2026-11-10 (Tuesday, before open, in 8 days) · EPS est. -0.82.

1-day std dev
6.8%
Finished up
50%
Biggest pop
+4.8%
Biggest drop
-14.3%

Standard deviation of the close-to-close move over the last 8 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-11 beat -0.83 -0.82 +0.7% -17.8% -14.3% -10.1%
2026-05-11 miss -0.65 -0.93 -42.6% -0.4% +1.5% -14.6%
2026-03-30 miss -0.65 -0.68 -4.0% +4.1% +3.6% +15.9%
2025-11-10 miss -0.53 -0.67 -25.5% +1.0% -4.8% +2.8%
2025-08-12 beat -0.54 -0.50 +6.8% -2.6% +4.8% +15.2%
2025-05-13 miss -0.40 -0.68 -70.8% +0.0% -8.1% +6.0%
2025-03-27 miss -0.28 -0.39 -38.0% +1.2% +2.3% -9.7%
2024-11-12 miss -0.50 -1.60 -220.0% -0.8% -7.3% -19.9%

Not investment advice.